AXSM Axsome Therapeutics, Inc. - Common Stock
$220,33
Kurs · Aug 19, 2026
Fundamentaldaten per Aug 10, 2026
52W-Spanne
$110–$260
74% of range
Analystenbewertung
BUY
28 analysts
Kursziel
$284
+29% upside
P/E (TTM)
-59.9
ROE
-227.0%
Nettogewinnmarge
-28.7%
AXSM Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$220.33
Marktkapitalisierung
$11.21B
P/E (TTM)
-59.9
EPS (TTM)
$-3.68
Umsatz (TTM)
$638M
Dividendenrendite
—
ROE
-227.0%
Verschuldungsgrad
2.1
52W-Spanne
$110 – $260
AXSM Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$638M
2022-12-31
→
2025-12-31
EPS
$-3.68
2020-12-31
→
2025-12-31
Freier Cashflow
$-94M
2016-12-31
→
2025-12-31
Margen
-28.7%
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
AXSM
Peer-Median
P/E (TTM)
-59.9
47.9
P/S (TTM) (K/V (TTM))
17.6
16.2
P/B (K/B)
127.0
9.3
EV / EBITDA
-66.4
—
Price / FCF (Kurs / FCF)
-119.4
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
AXSM
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-26.1%
—
Net Profit Margin (Nettogewinnmarge)
-28.7%
5.1%
ROA
-29.1%
0.81%
ROE
-227.0%
-15.3%
ROIC
-60.2%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
AXSM
Peer-Median
Debt / Equity (Fremdkapital / Eigenkapital)
2.1
—
Current Ratio (Liquiditätsgrad)
1.6
2.7
Quick Ratio
1.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
AXSM
Peer-Median
Revenue YoY (Umsatz YoY)
65.5%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
133.7%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
AXSM
Peer-Median
AXSM Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
KAUF
28 Analysten
- Starker Kauf 10 35,7%
- Kauf 16 57,1%
- Halten 2 7,1%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
21 Analysten · 2026-08-14
Median
$276.00
← Unter allen Zielen
$220.33
Tief
$246.00
Hoch
$380.00
Median-Ziel
$276.00
+25,3%
Mittelwert-Ziel
$283.90
+28,9%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.02%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.99 | $-0.86 | -0.13% |
| 31. März 2026 | $-1.26 | $-0.91 | -0.35% |
| 31. Dezember 2025 | $-0.56 | $-0.68 | 0.12% |
| 30. September 2025 | $-0.94 | $-0.88 | -0.06% |
| 30. Juni 2025 | $-0.97 | $-1.12 | 0.15% |
| 31. März 2025 | $-1.22 | $-1.35 | 0.13% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| AXSM | $9.29B | -49.6 | 65.5% | -28.7% | -227.0% | — |
| ZTS | $53.46B | 20.9 | 2.3% | 28.2% | 66.0% | — |
| VTRS | — | -4.2 | -3.0% | -24.6% | -23.2% | 35.1% |
| CORT | $3.69B | 42.4 | 12.8% | 13.1% | 15.5% | — |
| ELAN | $11.25B | -48.1 | 6.2% | -4.9% | -3.5% | 55.0% |
| CRNX | $4.45B | -9.4 | 640.7% | -6046.2% | -43.0% | — |
| LQDA | $3.01B | -43.1 | 1031.2% | -43.5% | -230.0% | — |
| BLTE | — | — | — | — | — | — |
| DFTX | $1.32B | -6.5 | 212.0% | — | -71.0% | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | $638M | $386M | $271M | $50M | |
| Cost of Revenue | · | · | · | $5M | |
| R&D Expense | $183M | $187M | $98M | $58M | |
| SG&A Expense | $571M | $411M | $323M | $159M | |
| Operating Expenses | $805M | $666M | $502M | $230M | |
| Operating Income | $-167M | $-281M | $-232M | $-180M | |
| Interest Expense | $-16M | $-22M | $-20M | $-10M | |
| Interest Income | $9M | $15M | $14M | $2M | |
| Pretax Income | $-184M | $-287M | $-238M | $-187M | |
| Income Tax | $-530.0K | $85.0K | $960.0K | $0 | |
| Net Income | $-183M | $-287M | $-239M | $-187M | |
| EPS (Basic) | $-3.68 | $-5.99 | $-5.27 | $-4.60 | |
| EPS (Diluted) | $-3.68 | $-5.99 | $-5.27 | $-4.60 | |
| Shares (Basic) | 49,747,178 | 47,914,253 | 45,425,212 | 40,655,941 | |
| Shares (Diluted) | 49,747,178 | 47,914,253 | 45,425,212 | 40,655,941 | |
| EBITDA | $-167M | $-281M | $-232M | $-180M |
Bilanz 20
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Cash & Equivalents | $323M | $315M | $386M | $201M | |
| Receivables | $224M | $142M | $95M | $38M | |
| Inventory | $28M | $16M | $15M | $4M | |
| Prepaid Expense | $14M | $12M | $8M | $3M | |
| Current Assets | $589M | $485M | $504M | $246M | |
| PP&E (Net) | $562.0K | $584.0K | $846.0K | $722.0K | |
| Goodwill | $12M | $12M | $12M | $10M | |
| Intangibles | $41M | $47M | $53M | $60M | |
| Total Assets | $690M | $568M | $588M | $331M | |
| Accounts Payable | $66M | $72M | $41M | $39M | |
| Current Liabilities | $379M | $230M | $139M | $97M | |
| Capital Leases | $23M | $6M | $7M | · | |
| Total Liabilities | $602M | $511M | $397M | $222M | |
| Long-term Debt | $188M | $181M | · | · | |
| Total Debt | $188M | $181M | $178M | $94M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $4.0K | |
| Retained Earnings | $-1.31B | $-1.12B | $-836M | $-596M | |
| Stockholders' Equity | $88M | $57M | $191M | $110M | |
| Liabilities + Equity | $690M | $568M | $588M | $331M | |
| Shares Outstanding | 50,882,766 | 48,667,587 | 47,351,363 | 43,498,617 |
Cashflow 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Stock-based Comp | $94M | $85M | $63M | $38M | |
| Amort. of Intangibles | $6M | $6M | $6M | $4M | |
| Operating Cash Flow | $-93M | $-128M | $-145M | $-117M | |
| CapEx | $480.0K | $270.0K | $582.0K | $702.0K | |
| Investing Cash Flow | $-480.0K | $-270.0K | $-582.0K | $-54M | |
| Net Debt Issued | $-332M | · | · | · | |
| Stock Issued | $68M | $41M | $259M | $244M | |
| Net Stock Activity | $68M | $41M | $259M | $237M | |
| Financing Cash Flow | $101M | $58M | $331M | $285M | |
| Net Change in Cash | $8M | $-71M | $185M | $114M | |
| Taxes Paid | $-180.0K | · | · | · | |
| Free Cash Flow | $-94M | $-129M | $-146M | $-117M | |
| Levered FCF | $-78M | $-107M | · | · |
Rentabilität 7
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Margin | -26.1% | -72.7% | -85.7% | · | |
| Net Margin | -28.7% | -74.5% | -88.4% | · | |
| Pretax Margin | -28.8% | -74.5% | -88.1% | · | |
| EBITDA Margin | -26.1% | -72.7% | -85.7% | · | |
| ROA | -29.1% | -49.7% | -52.0% | -89.3% | |
| ROE | -227.0% | -383.2% | -103.9% | -140.2% | |
| ROIC | -60.2% | -118.1% | -63.1% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Current Ratio | 1.6 | 2.1 | 3.6 | 2.5 | |
| Quick Ratio | 1.4 | 2.0 | 3.5 | 2.5 | |
| Debt / Equity | 2.1 | 3.2 | 0.9 | 0.9 | |
| LT Debt / Equity | 1.3 | 3.2 | 0.9 | 0.9 | |
| Interest Coverage | 10.5 | 13.0 | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Asset Turnover | 1.0 | 0.7 | 0.6 | 0.0 | |
| Inventory Turnover | · | · | · | 2.4 | |
| Receivables Turnover | 3.5 | 3.3 | 4.1 | 0.0 |
Wachstumsraten 2
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue YoY | 65.5% | 42.5% | 440.8% | · | |
| Revenue CAGR 3Y | 133.7% | · | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue TTM | $638M | $386M | $271M | $50M | |
| Net Income TTM | $-183M | $-287M | $-239M | $-187M | |
| Market Cap | $9.29B | $4.12B | $3.77B | $3.36B | |
| Enterprise Value | $9.16B | $3.98B | $3.56B | $3.25B | |
| P/E | -49.6 | -14.1 | -15.1 | -16.8 | |
| P/S | 14.6 | 10.7 | 13.9 | 67.1 | |
| P/B | 105.3 | 72.2 | 19.7 | 30.6 | |
| P / Tangible Book | 260.1 | · | 30.0 | 84.8 | |
| P / Cash Flow | -99.5 | -32.1 | -26.0 | -28.8 | |
| P / FCF | -99.0 | -32.0 | -25.9 | -28.6 | |
| EV / EBITDA | -54.9 | -14.2 | -15.4 | -18.1 | |
| EV / FCF | -97.5 | -31.0 | -24.4 | -27.7 | |
| EV / Revenue | 14.3 | 10.3 | 13.2 | 64.9 | |
| Earnings Yield | -2.0% | -7.1% | -6.6% | -6.0% |
Gewinn- und Verlustrechnung 16
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $218M | $191M | $196M | $171M | $150M | $121M | $119M | $105M | $87M | $75M | $72M | $58M | $47M | $95M | $24M | $17M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2M | |
| R&D Expense | $46M | $53M | $49M | $40M | $50M | $45M | $55M | $45M | $50M | $37M | $31M | $29M | $21M | $18M | $15M | $15M | |
| SG&A Expense | $208M | $185M | $169M | $150M | $130M | $121M | $113M | $96M | $104M | $99M | $87M | $83M | $79M | $74M | $61M | $41M | |
| Operating Expenses | $268M | $255M | $223M | $217M | $187M | $178M | $191M | $167M | $165M | $142M | $170M | $120M | $112M | $101M | $84M | $59M | |
| Operating Income | $-50M | $-63M | $-27M | $-46M | $-37M | $-57M | $-73M | $-63M | $-78M | $-67M | $-98M | $-62M | $-65M | $-6M | $-60M | $-42M | |
| Interest Expense | $-3M | $3M | $-3M | $-3M | $-4M | $5M | $-5M | $-6M | $-5M | $-5M | · | · | · | · | · | · | |
| Interest Income | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $4M | $4M | $4M | · | · | · | · | · | · | |
| Pretax Income | $-51M | $-65M | $-28M | $-47M | $-49M | $-59M | $-75M | $-65M | $-79M | $-68M | $-99M | $-63M | $-68M | $-9M | $-61M | $-45M | |
| Income Tax | $128.0K | $0 | $430.0K | $0 | $-960.0K | $0 | $85.0K | $0 | $0 | $0 | $-325.0K | $-678.0K | $-617.0K | $3M | · | $0 | |
| Net Income | $-51M | $-65M | $-29M | $-47M | $-48M | $-59M | $-75M | $-65M | $-79M | $-68M | $-99M | $-62M | $-67M | $-11M | $-61M | $-45M | |
| EPS (Basic) | $-0.99 | $-1.26 | $-0.55 | $-0.94 | $-0.97 | $-1.22 | $-1.54 | $-1.34 | $-1.67 | $-1.44 | $-2.15 | $-1.32 | $-1.54 | $-0.26 | $-1.41 | $-1.07 | |
| EPS (Diluted) | $-0.99 | $-1.26 | $-0.55 | $-0.94 | $-0.97 | $-1.22 | $-1.54 | $-1.34 | $-1.67 | $-1.44 | $-2.15 | $-1.32 | $-1.54 | $-0.26 | $-1.41 | $-1.07 | |
| Shares (Basic) | 51,799,708 | 51,198,349 | -98,587,837 | 50,021,851 | 49,442,001 | 48,871,163 | -95,193,058 | 48,140,519 | 47,573,229 | 47,393,563 | -88,885,435 | 47,117,196 | 43,669,820 | 43,523,631 | -78,452,688 | 41,704,362 | |
| Shares (Diluted) | 51,799,708 | 51,198,349 | -98,587,837 | 50,021,851 | 49,442,001 | 48,871,163 | -95,193,058 | 48,140,519 | 47,573,229 | 47,393,563 | -88,885,435 | 47,117,196 | 43,669,820 | 43,523,631 | -78,452,688 | 41,704,362 | |
| EBITDA | $-50M | $-63M | · | $-46M | $-37M | $-57M | · | $-63M | $-78M | $-67M | · | $-62M | $-65M | $-6M | · | $-42M |
Bilanz 20
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $320M | $305M | $323M | $325M | $303M | $301M | $315M | $327M | $316M | $331M | · | $417M | $437M | $247M | · | $228M | |
| Receivables | $277M | $251M | $224M | $197M | $199M | $161M | $142M | $124M | $120M | $101M | · | $78M | $67M | $45M | · | $20M | |
| Inventory | $38M | $32M | $28M | $24M | $18M | $16M | $16M | $14M | $15M | $16M | · | $10M | $9M | $8M | · | $2M | |
| Prepaid Expense | $21M | $24M | $14M | $20M | $16M | $16M | $12M | $13M | $12M | $12M | · | $7M | $6M | $5M | · | $2M | |
| Current Assets | $657M | $611M | $589M | $565M | $537M | $495M | $485M | $479M | $463M | $460M | · | $512M | $520M | $304M | · | $252M | |
| PP&E (Net) | $874.0K | $567.0K | $562.0K | $605.0K | $667.0K | $773.0K | $584.0K | $683.0K | $724.0K | $812.0K | · | $971.0K | $736.0K | $703.0K | · | $627.0K | |
| Goodwill | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | · | $12M | $12M | $10M | · | $12M | |
| Intangibles | $37M | $39M | $41M | $42M | $44M | $45M | $47M | $49M | $50M | $52M | · | $55M | $56M | $58M | · | $61M | |
| Total Assets | $761M | $714M | $690M | $669M | $640M | $597M | $568M | $561M | $548M | $546M | · | $601M | $612M | $389M | · | $339M | |
| Accounts Payable | $79M | $107M | $66M | $54M | $92M | $86M | $72M | $64M | $61M | $54M | · | $29M | $43M | $36M | · | $13M | |
| Current Liabilities | $460M | $439M | $379M | $360M | $342M | $244M | $230M | $196M | $187M | $144M | · | $115M | $115M | $101M | · | $60M | |
| Capital Leases | $22M | $22M | $23M | $23M | $24M | $24M | $6M | $6M | $7M | $7M | · | $8M | $8M | · | · | · | |
| Total Liabilities | $678M | $659M | $602M | $596M | $567M | $543M | $511M | $469M | $445M | $402M | · | $331M | $333M | $277M | · | $182M | |
| Long-term Debt | $188M | $188M | $188M | $188M | $188M | · | $181M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $188M | $188M | · | $188M | $188M | $181M | · | $180M | $179M | $179M | · | $177M | $177M | $148M | · | $94M | |
| Common Stock | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | · | $5.0K | $5.0K | $4.0K | · | $4.3K | |
| Retained Earnings | $-1.42B | $-1.37B | $-1.31B | $-1.28B | $-1.23B | $-1.18B | $-1.12B | $-1.05B | $-983M | $-904M | · | $-737M | $-675M | $-608M | · | $-535M | |
| Stockholders' Equity | $83M | $55M | $88M | $74M | $73M | $53M | $57M | $93M | $103M | $144M | $191M | $270M | $279M | $112M | $110M | $157M | |
| Liabilities + Equity | $761M | $714M | $690M | $669M | $640M | $597M | $568M | $561M | $548M | $546M | · | $601M | $612M | $389M | · | $339M | |
| Shares Outstanding | 52,299,889 | 51,420,445 | 50,882,766 | 50,307,834 | 49,815,301 | 49,216,759 | 48,667,587 | 48,436,108 | 47,801,578 | 47,464,575 | · | 47,317,381 | 46,726,794 | 43,548,466 | · | 43,425,707 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $27M | $23M | $23M | $23M | $25M | $23M | $22M | $22M | $21M | $20M | $19M | $15M | $16M | $13M | $11M | $9M | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Operating Cash Flow | $-33M | $-21M | $-19M | $1M | $-32M | $-43M | $-26M | $-19M | $-30M | $-53M | $-30M | $-54M | $-55M | $-6M | $-28M | $-23M | |
| CapEx | $450.0K | $121.0K | $71.0K | $58.0K | $13.0K | $338.0K | $30.0K | $90.0K | $52.0K | $98.0K | $7.0K | $371.0K | $133.0K | $71.0K | $181.0K | $65.8K | |
| Investing Cash Flow | $-450.0K | $-121.0K | $-71.0K | $-58.0K | $-13.0K | $-338.0K | $-30.0K | $-90.0K | $-52.0K | $-98.0K | $-7.0K | $-371.0K | $-133.0K | $-71.0K | $-181.0K | $-65.8K | |
| Net Debt Issued | · | $-70M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Stock Issued | $13M | $6M | $6M | $10M | $33M | $20M | $16M | $13M | · | · | $0 | $34M | · | · | $0 | $182M | |
| Net Stock Activity | · | $6M | · | · | · | $20M | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $48M | $3M | $16M | $21M | $35M | $29M | $14M | $30M | $14M | $-1M | $-2.0K | $33M | $246M | $52M | $1M | $177M | |
| Net Change in Cash | $15M | $-18M | $-2M | $22M | $2M | $-14M | $-12M | $12M | $-16M | $-55M | $-30M | $-21M | $191M | $46M | $-27M | $154M | |
| Free Cash Flow | · | $-21M | · | · | · | $-44M | · | · | · | $-54M | · | · | · | $-6M | · | · | |
| Levered FCF | · | $-24M | · | · | · | $-38M | · | · | · | · | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -22.7% | -33.1% | · | -27.0% | -24.5% | -46.9% | · | -59.8% | -89.5% | -89.7% | · | -107.5% | · | -6.7% | · | · | |
| Net Margin | -23.5% | -33.8% | · | -27.6% | -32.0% | -48.9% | · | -61.7% | -91.0% | -91.1% | · | -107.6% | · | -11.9% | · | · | |
| Pretax Margin | -23.4% | -33.8% | · | -27.6% | -32.6% | -48.9% | · | -61.7% | -91.0% | -91.1% | · | -108.8% | · | -9.1% | · | · | |
| EBITDA Margin | -22.7% | -33.1% | · | -27.0% | -24.5% | -46.9% | · | -59.8% | -89.5% | -89.7% | · | -107.5% | · | -6.7% | · | · | |
| ROA | -7.3% | -9.8% | · | -7.7% | -8.1% | -10.4% | · | -11.1% | -13.7% | -14.6% | · | -13.2% | -17.0% | -4.7% | · | -19.7% | |
| ROE | -65.6% | -119.8% | · | -56.7% | -54.5% | -60.2% | · | -35.6% | -41.6% | -53.4% | · | -29.1% | -45.7% | -17.7% | · | -44.8% | |
| ROIC | -18.4% | -26.1% | · | -17.6% | -13.8% | -24.3% | · | -22.9% | -27.7% | -20.8% | · | -13.8% | -14.1% | -3.2% | · | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.4 | 1.4 | · | 1.6 | 1.6 | 2.0 | · | 2.4 | 2.5 | 3.2 | · | 4.5 | 4.5 | 3.0 | · | 4.2 | |
| Quick Ratio | 1.3 | 1.3 | · | 1.4 | 1.5 | 1.9 | · | 2.3 | 2.3 | 3.0 | · | 4.3 | 4.4 | 2.9 | · | 4.1 | |
| Debt / Equity | 2.3 | 3.4 | · | 2.5 | 2.6 | 3.4 | · | 1.9 | 1.7 | 1.2 | · | 0.7 | 0.6 | 1.3 | · | 0.6 | |
| LT Debt / Equity | 1.4 | 2.2 | · | 1.6 | 1.6 | 3.4 | · | 1.9 | 1.7 | 1.2 | · | 0.7 | 0.6 | 1.3 | · | 0.6 | |
| Interest Coverage | 15.5 | -20.5 | · | 13.7 | 9.0 | 10.8 | · | · | · | · | · | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | · | 0.4 | · | · | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | 1.8 | |
| Receivables Turnover | 0.9 | 0.9 | · | 1.1 | 0.9 | 0.9 | · | 1.0 | 0.9 | 1.0 | · | 1.2 | · | 4.2 | · | · |
Bewertung (TTM) 14
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $731M | $634M | · | $547M | $463M | $388M | · | $325M | $267M | $274M | · | $216M | · | · | · | · | |
| Net Income TTM | $-211M | $-219M | · | $-219M | $-251M | $-272M | · | $-275M | $-277M | $-209M | · | $-185M | $-165M | $-137M | · | $-161M | |
| Market Cap | $12.80B | $8.69B | · | $6.11B | $5.20B | $5.74B | · | $4.35B | $3.85B | $3.79B | · | $3.31B | $3.36B | $2.69B | · | $1.94B | |
| Enterprise Value | $12.67B | $8.57B | · | $5.97B | $5.08B | $5.62B | · | $4.21B | $3.71B | $3.63B | · | $3.07B | $3.10B | $2.59B | · | $1.80B | |
| P/E | -58.8 | -38.5 | · | -27.2 | -20.1 | -20.6 | · | -15.6 | -13.5 | -17.5 | · | -16.7 | -18.3 | -17.9 | · | -10.8 | |
| P/S | 17.5 | 13.7 | · | 11.2 | 11.2 | 14.8 | · | 13.4 | 14.4 | 13.8 | · | 15.3 | · | · | · | · | |
| P/B | 153.7 | 159.2 | · | 82.9 | 71.2 | 107.9 | · | 46.9 | 37.4 | 26.3 | · | 12.3 | 12.0 | 24.0 | · | 12.3 | |
| P / Tangible Book | 377.6 | 2415.5 | · | 312.4 | 300.6 | · | · | 134.5 | 94.5 | 47.2 | · | 16.3 | 16.0 | 61.9 | · | 23.0 | |
| P / Cash Flow | · | -419.9 | · | · | · | -132.3 | · | · | · | -70.8 | · | · | · | -461.4 | · | · | |
| P / FCF | · | -417.4 | · | · | · | -131.3 | · | · | · | -70.7 | · | · | · | -455.9 | · | · | |
| EV / EBITDA | -255.2 | -135.3 | · | -129.5 | -138.5 | -98.6 | · | -67.2 | -47.6 | -54.0 | · | -49.4 | -47.6 | -405.9 | · | -42.5 | |
| EV / FCF | · | -411.8 | · | · | · | -128.6 | · | · | · | -67.9 | · | · | · | -439.1 | · | · | |
| EV / Revenue | 17.3 | 13.5 | · | 10.9 | 11.0 | 14.5 | · | 13.0 | 13.9 | 13.3 | · | 14.2 | · | · | · | · | |
| Earnings Yield | -1.7% | -2.6% | · | -3.7% | -5.0% | -4.9% | · | -6.4% | -7.4% | -5.7% | · | -6.0% | -5.5% | -5.6% | · | -9.2% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $638M | $386M | $271M | $50M | — |
| Betriebsgewinnmarge % | -26.1% | -72.7% | -85.7% | — | — |
| Nettoergebnis | $-183M | $-287M | $-239M | $-187M | $-130M |
| Verwässerte EPS | $-3.68 | $-5.99 | $-5.27 | $-4.60 | $-3.47 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 2.1 | 3.2 | 0.9 | 0.9 | 3.1 |
| Liquiditätsgrad | 1.6 | 2.1 | 3.6 | 2.5 | 3.8 |
| Quick Ratio | 1.4 | 2.0 | 3.5 | 2.5 | 3.7 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $-94M | $-129M | $-146M | $-117M | $-109M |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 554 Einreicher · $7.0B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 150 (+75 vs. Vorquartal) | 32 (-20 vs. Vorquartal) | 156 (+13 vs. Vorquartal) | 155 (+7 vs. Vorquartal) | +6.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD PORTFOLIO MANAGEMENT LLC | $485.504.722 | 1.983.514 | 6,95% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $480.994.100 | 1.965.086 | 6,88% | Aktien |
| FMR LLC | $320.410.784 | 1.309.028 | 4,59% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $209.486.017 | 855.638 | 3,00% | Aktien |
| STATE STREET CORP | $192.289.814 | 785.661 | 2,75% | Aktien |
| Deep Track Capital, LP | $171.339.000 | 700.000 | 2,45% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $163.868.130 | 669.478 | 2,35% | Aktien |
| ALETHEA CAPITAL MANAGEMENT, LLC | $158.796.006 | 648.756 | 2,27% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $136.113.660 | 556.088 | 1,95% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $132.031.000 | 539.407 | 1,89% | Aktien |
| NORGES BANK | $125.876.889 | 514.266 | 1,80% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $118.906.084 | 485.787 | 1,70% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $118.811.358 | 485.400 | 1,70% | Verkaufsoption |
| FIRST TRUST ADVISORS LP | $117.994.070 | 482.061 | 1,69% | Aktien |
| Assenagon Asset Management S.A. | $111.292.513 | 454.682 | 1,59% | Aktien |
| Pictet Asset Management Holding SA | $104.399.930 | 426.527 | 1,49% | Aktien |
| Qube Research & Technologies Ltd | $104.354.263 | 426.336 | 1,49% | Aktien |
| Point72 Asset Management, L.P. | $101.950.621 | 416.516 | 1,46% | Aktien |
| AMERIPRISE FINANCIAL INC | $101.059.520 | 412.873 | 1,45% | Aktien |
| Hood River Capital Management LLC | $98.563.494 | 402.678 | 1,41% | Aktien |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $91.315.610 | 373.067 | 1,31% | Aktien |
| Driehaus Capital Management LLC | $91.170.461 | 372.474 | 1,30% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $81.802.134 | 334.200 | 1,17% | Kaufoption |
| PRINCIPAL FINANCIAL GROUP INC | $81.420.780 | 332.642 | 1,17% | Aktien |
| EVENTIDE ASSET MANAGEMENT, LLC | $77.534.680 | 316.820 | 1,11% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $77.371.552 | 316.099 | 1,11% | Aktien |
| Integral Health Asset Management, LLC | $73.431.000 | 300.000 | 1,05% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $68.471.470 | 279.738 | 0,98% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $64.129.740 | 262.000 | 0,92% | Aktien |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $63.403.752 | 259.034 | 0,91% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $62.240.116 | 254.280 | 0,89% | Aktien |
| Clearbridge Investments, LLC | $60.109.141 | 245.574 | 0,86% | Aktien |
| BANK OF AMERICA CORP /DE/ | $56.991.512 | 232.837 | 0,82% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $56.530.611 | 230.954 | 0,81% | Aktien |
| CANADA PENSION PLAN INVESTMENT BOARD | $55.171.158 | 225.400 | 0,79% | Aktien |
| PFM Health Sciences, LP | $53.750.513 | 219.596 | 0,77% | Aktien |
| Tri Locum Partners LP | $53.680.019 | 219.308 | 0,77% | Aktien |
| First Turn Management, LLC | $53.461.440 | 218.415 | 0,77% | Aktien |
| LOOMIS SAYLES & CO L P | $48.747.659 | 199.157 | 0,70% | Aktien |
| JANE STREET GROUP, LLC | $42.859.227 | 175.100 | 0,61% | Kaufoption |
| JANE STREET GROUP, LLC | $41.782.239 | 170.700 | 0,60% | Verkaufsoption |
| Woodline Partners LP | $39.706.834 | 162.221 | 0,57% | Aktien |
| Sofinnova Investments, Inc. | $39.268.206 | 160.429 | 0,56% | Aktien |
| CITADEL ADVISORS LLC | $38.257.551 | 156.300 | 0,55% | Verkaufsoption |
| Squarepoint Ops LLC | $37.842.666 | 154.605 | 0,54% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $35.527.142 | 145.145 | 0,51% | Aktien |
| TWO SIGMA ADVISERS, LP | $34.427.640 | 188.500 | 0,49% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $33.091.680 | 135.195 | 0,47% | Aktien |
| CITIGROUP INC | $33.040.768 | 134.987 | 0,47% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $31.997.069 | 130.723 | 0,46% | Aktien |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $29.127.385 | 118.999 | 0,42% | Aktien |
| PERCEPTIVE ADVISORS LLC | $28.993.007 | 118.450 | 0,42% | Aktien |
| ORBIMED ADVISORS LLC | $28.779.567 | 117.578 | 0,41% | Aktien |
| Public Sector Pension Investment Board | $28.393.320 | 116.000 | 0,41% | Aktien |
| GOLDMAN SACHS GROUP INC | $28.165.439 | 115.069 | 0,40% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $27.257.832 | 111.361 | 0,39% | Aktien |
| EMERALD ADVISERS, LLC | $25.514.090 | 104.237 | 0,37% | Aktien |
| JANE STREET GROUP, LLC | $25.423.770 | 103.868 | 0,36% | Aktien |
| CITADEL ADVISORS LLC | $25.211.310 | 103.000 | 0,36% | Kaufoption |
| Nicholas Investment Partners, LP | $24.225.866 | 98.974 | 0,35% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $23.913.539 | 97.698 | 0,34% | Aktien |
| ALGERT GLOBAL LLC | $23.335.148 | 95.335 | 0,33% | Aktien |
| SAMLYN CAPITAL, LLC | $22.984.882 | 93.904 | 0,33% | Aktien |
| ROYCE & ASSOCIATES LP | $22.284.106 | 91.041 | 0,32% | Aktien |
| MetLife Investment Management, LLC | $21.946.568 | 89.662 | 0,31% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $21.494.478 | 87.815 | 0,31% | Aktien |
| Voleon Capital Management LP | $20.666.665 | 84.433 | 0,30% | Aktien |
| Cannell & Spears LLC | $20.598.375 | 84.154 | 0,29% | Aktien |
| Trexquant Investment LP | $20.482.109 | 83.679 | 0,29% | Aktien |
| Man Group plc | $20.199.889 | 82.526 | 0,29% | Aktien |
| Granite Investment Partners, LLC | $19.611.951 | 80.124 | 0,28% | Aktien |
| Weiss Asset Management LP | $19.581.600 | 80.000 | 0,28% | Aktien |
| Swiss National Bank | $19.459.215 | 79.500 | 0,28% | Aktien |
| Aberdeen Group plc | $19.149.826 | 78.236 | 0,27% | Aktien |
| Balyasny Asset Management L.P. | $18.663.713 | 76.250 | 0,27% | Aktien |
| California Public Employees Retirement System | $18.303.411 | 74.778 | 0,26% | Aktien |
| WCM INVESTMENT MANAGEMENT, LLC | $18.255.919 | 75.713 | 0,26% | Aktien |
| Science & Technology Partners, L.P. | $17.878.001 | 73.040 | 0,26% | Aktien |
| EMERALD MUTUAL FUND ADVISERS TRUST | $16.447.320 | 67.195 | 0,24% | Aktien |
| US BANCORP \DE\ | $16.295.807 | 66.576 | 0,23% | Aktien |
| DNB Asset Management AS | $15.958.759 | 65.199 | 0,23% | Aktien |
| Eagle Health Investments LP | $15.922.533 | 65.051 | 0,23% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $15.555.379 | 63.551 | 0,22% | Aktien |
| Rhenman & Partners Asset Management AB | $15.432.748 | 63.050 | 0,22% | Aktien |
| IFP Advisors, Inc | $15.242.562 | 62.273 | 0,22% | Aktien |
| NEW YORK STATE COMMON RETIREMENT FUND | $14.936.844 | 61.024 | 0,21% | Aktien |
| BlackRock, Inc. | $14.689.872 | 60.015 | 0,21% | Aktien |
| Caption Management, LLC | $14.686.200 | 60.000 | 0,21% | Kaufoption |
| ALLIANCEBERNSTEIN L.P. | $14.487.718 | 85.716 | 0,21% | Aktien |
| M&G PLC | $14.449.120 | 58.976 | 0,21% | Aktien |
| Bridgewater Associates, LP | $14.249.775 | 58.217 | 0,20% | Aktien |
| Nuveen, LLC | $14.087.982 | 57.556 | 0,20% | Aktien |
| HighTower Advisors, LLC | $13.783.733 | 56.313 | 0,20% | Aktien |
| PEAK6 LLC | $13.756.074 | 56.200 | 0,20% | Kaufoption |
| Hillsdale Investment Management Inc. | $13.462.350 | 55.000 | 0,19% | Aktien |
| SUPERSTRING CAPITAL MANAGEMENT LP | $13.197.019 | 53.916 | 0,19% | Aktien |
| Caption Management, LLC | $13.095.195 | 53.500 | 0,19% | Verkaufsoption |
| OMERS ADMINISTRATION Corp | $12.402.741 | 50.671 | 0,18% | Aktien |
| HB Wealth Management, LLC | $12.346.199 | 50.440 | 0,18% | Aktien |
| IRIDIAN ASSET MANAGEMENT LLC/CT | $11.730.357 | 47.924 | 0,17% | Aktien |
Unternehmensinsider 14 Insider · 8 Führungskräfte · 5 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Nick Pizzie | Chief Financial Officer | 9. Juni 2026 M | 42.867 | 0 | 2 | $-10.178.010 |
| John Golubieski | Chief Financial Officer | 4. August 2017 A | — | 0 | 0 | $0 |
| Mark L. Jacobson | Chief Operating Officer | 5. Mai 2026 M | 0 | 0 | 6 | $-13.210.489 |
| Ari Maizel | Chief Commercial Officer | 22. April 2026 M | 0 | 0 | 2 | $-2.751.450 |
| Hunter R. Murdock | General Counsel | 21. April 2026 A | 0 | 0 | 0 | $0 |
| David C Marek | Chief Commercial Officer | 17. März 2020 A | — | 0 | 0 | $0 |
| Constance Ames | Vice President, Finance | 15. März 2017 A | 4.358 | 0 | 0 | $0 |
| Randall Kaye | Chief Medical Officer | 23. Dezember 2015 P | 6.022 | 0 | 0 | $0 |
| Roger Jeffs | Direktor | 11. Juni 2026 S | 58.367 | 0 | 8 | $-13.515.499 |
| Mark Coleman | Direktor | 8. Juni 2026 M | 30.389 | 3 | 5 | $-8.006.861 |
| Susan Mahony | Direktor | 8. Juni 2026 M | 829 | 0 | 2 | $-145.017 |
| Mark E Saad | Direktor | 8. Juni 2026 M | 11.431 | 0 | 3 | $-7.348.483 |
| Myrtle S Potter | Direktor | 7. Juni 2019 A | — | 0 | 0 | $0 |
| Herriot Tabuteau | — | 6. August 2026 M | 7.229 | 0 | 20 | $-110.582.644 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Antecip Capital LLC, Herriot Tabuteau, M.D. | 4. Dezember 2015 | — | Erste Einreichung | Passive Anlage | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 69 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 3,87% | 44.930 SH | 8. August 2026 | Täglich |
| IBRN · iShares Trust | 3,45% | 1.265 SH | 8. August 2026 | Täglich |
| LFSC · RBB Fund, Inc. | 2,84% | 12.723 NS | 31. Mai 2026 | N-PORT |
| BBP · ETFis Series Trust I | 2,24% | 6.386 NS | 30. April 2026 | N-PORT |
| IHE · iShares Trust | 2,00% | 154.403 SH | 8. August 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,74% | 1.081 NS | 30. April 2026 | N-PORT |
| FMED · Fidelity Covington Trust | 1,57% | 2.752 NS | 31. Mai 2026 | N-PORT |
| SAWS · ETF Series Solutions | 0,89% | 301 NS | 30. April 2026 | N-PORT |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,75% | 2.802 SH | 8. August 2026 | Täglich |
| IBB · iShares Trust | 0,70% | 316.215 SH | 8. August 2026 | Täglich |
| FNY · First Trust Exchange-Traded AlphaDE… | 0,65% | 16.227 NS | 30. April 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,62% | 7.314 NS | 31. Mai 2026 | N-PORT |
| BIB · ProShares Trust | 0,60% | 1.890 NS | 31. Mai 2026 | N-PORT |
| PDP · Invesco Exchange-Traded Fund Trust | 0,60% | 42.533 SH | 8. August 2026 | Täglich |
| ESSC · Strategy Shares | 0,57% | 712 NS | 30. April 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,57% | 787 NS | 31. Mai 2026 | N-PORT |
| MMSC · First Trust Exchange-Traded Fund VI… | 0,51% | 1.129 NS | 31. Mai 2026 | N-PORT |
| SMLF · iShares Trust | 0,41% | 82.609 SH | 8. August 2026 | Täglich |
| HQGO · Lattice Strategies Trust | 0,35% | 813 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,35% | 14.725 NS | 31. Mai 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,30% | 2.075 NS | 31. Mai 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,29% | 579.303 SH | 8. August 2026 | Täglich |
| ISCG · iShares Trust | 0,28% | 13.202 SH | 8. August 2026 | Täglich |
| RSSL · Global X Funds | 0,26% | 17.928 NS | 30. April 2026 | N-PORT |
| IWP · iShares Trust | 0,26% | 248.939 SH | 8. August 2026 | Täglich |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,25% | 16.111 NS | 30. April 2026 | N-PORT |
| SMMV · iShares Trust | 0,25% | 3.431 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,24% | 1.951 NS | 31. Mai 2026 | N-PORT |
| SXQG · EXCHANGE TRADED CONCEPTS TRUST | 0,21% | 610 NS | 31. Mai 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,21% | 203.437 NS | 31. Mai 2026 | N-PORT |
| BKMC · BNY Mellon ETF Trust | 0,20% | 6.089 NS | 30. April 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,19% | 4.463 NS | 30. April 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,18% | 14.304 SH | 8. August 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,16% | 15.904 NS | 30. April 2026 | N-PORT |
| IYH · iShares Trust | 0,15% | 25.759 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,14% | 1.526 NS | 31. Mai 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,14% | 119.127 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,14% | 1.874 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,13% | 1.003.143 SH | 8. August 2026 | Täglich |
| SMMD · iShares Trust | 0,12% | 21.500 SH | 8. August 2026 | Täglich |
| VXF · VANGUARD INDEX FUNDS | 0,12% | 495.949 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 16.077 NS | 30. April 2026 | N-PORT |
| ESML · iShares Trust | 0,11% | 14.809 SH | 8. August 2026 | Täglich |
| URTY · ProShares Trust | 0,10% | 1.544 NS | 31. Mai 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,10% | 1.871 SH | 8. August 2026 | Täglich |
| LRGF · iShares Trust | 0,09% | 16.283 SH | 8. August 2026 | Täglich |
| ROUS · Lattice Strategies Trust | 0,08% | 2.350 NS | 30. April 2026 | N-PORT |
| WSML · iShares Trust | 0,08% | 2.422 SH | 8. August 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,07% | 2.924 SH | 8. August 2026 | Täglich |
| IWR · iShares Trust | 0,06% | 175.575 SH | 8. August 2026 | Täglich |